1BP-LSD

Last updated
1BP-LSD
1BP-LSD structure.png
Clinical data
Other names1-(3-(Tetramethyldioxa-borolane)propionyl)-LSD
Routes of
administration 		Oral [1]
Drug class Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Identifiers
  • (6aR,9R)-N,N-diethyl-7-methyl-4-(4-(4,4,5,5-tetraethyl-1,3,2-dioxaborolan-2-yl)benzoyl)-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
Chemical and physical data
Formula C37H48BN3O4
Molar mass 609.62 g·mol−1
3D model (JSmol)
  • CCN(CC)C(=O)[C]1CN(C)[C@@H]2Cc3cn(C(=O)c4ccc(cc4)B5OC(CC)(CC)C(CC)(CC)O5)c6cccc(C2=C1)c36
  • InChI=UPWXYDVQVMGNAT-JGCGQSQUSA-N
  • Key:1S/C37H47BN3O4/c1-8-36(9-2)37(10-3,11-4)45-38(44-36)28-19-17-25(18-20-28)35(43)41-24-26-22-32-30(29-15-14-16-31(41)33(26)29)21-27(23-39(32)7)34(42)40(12-5)13-6/h14-21,24,32H,8-13,22-23H2,1-7H3/t32-/m1/s1

1BP-LSD, also known as 1-(3-(tetramethyldioxaborolane)propionyl)-LSD, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). [1] It is thought to be a prodrug of LSD. [1] The drug was encountered online as a novel designer drug in December 2025. [1] 1BP-LSD has been sold in the form of blotter containing 175 and 200 μg per tab. [1] It has been said to be considered to be the official legal successor of 1S-LSD, which was banned in Germany soon before 1BP-LSD's appearance. [1] The effects of 1BP-LSD are said to be similar to those of 1S-LSD and to include visual changes, altered perception of time and space, heightened emotions, and increased creativity. [1]

Contents

See also

References

  1. 1 2 3 4 5 6 7 "1BP-LSD". АИПСИН (in Russian). Retrieved 5 January 2026.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.